BR112012006842A2 - derivados de 3,5-diciano-4-(1h-indazol-5-il)-2,6-dimetil-1,4-dihidropiridina flúor substituídos e seus métodos de uso - Google Patents

derivados de 3,5-diciano-4-(1h-indazol-5-il)-2,6-dimetil-1,4-dihidropiridina flúor substituídos e seus métodos de uso

Info

Publication number
BR112012006842A2
BR112012006842A2 BR112012006842A BR112012006842A BR112012006842A2 BR 112012006842 A2 BR112012006842 A2 BR 112012006842A2 BR 112012006842 A BR112012006842 A BR 112012006842A BR 112012006842 A BR112012006842 A BR 112012006842A BR 112012006842 A2 BR112012006842 A2 BR 112012006842A2
Authority
BR
Brazil
Prior art keywords
indazol
dicyano
dimethyl
methods
dihydropyridine derivatives
Prior art date
Application number
BR112012006842A
Other languages
English (en)
Inventor
Alexandros Vakalopoulos
Donald Bierer
Karen Engel
Katja Zimmermann
Maria Kissel
Mario Lobell
Markus Follmann
Martin Michels
Nicole Teusch
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of BR112012006842A2 publication Critical patent/BR112012006842A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

derivados de 3,5-diciano-4-(1h-indazol-5-il)2,6-dimetil-1,4-dihidropiridina fluor substituidos e seus metodos de uso. a presente invenção se refere a novos derivados de 3,5-diciano-4-(1h-indazol-5-il) 2,6-dimetil 1,4-dihidropiridina fluor substituído tendo atividades inibidora da proteina tirosina quinase, a um processo para a sua produção e ao seus uso para o tratamento de doenças mediadas por c-met ou condições mediadas por c-met câncer e outras doenças proliferativas.
BR112012006842A 2009-10-06 2010-10-01 derivados de 3,5-diciano-4-(1h-indazol-5-il)-2,6-dimetil-1,4-dihidropiridina flúor substituídos e seus métodos de uso BR112012006842A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09172304 2009-10-06
PCT/EP2010/064648 WO2011042368A1 (en) 2009-10-06 2010-10-01 Fluoro-substituted 3,5-dicyano-4-(1h-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives and methods of use thereof

Publications (1)

Publication Number Publication Date
BR112012006842A2 true BR112012006842A2 (pt) 2016-06-07

Family

ID=43357944

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012006842A BR112012006842A2 (pt) 2009-10-06 2010-10-01 derivados de 3,5-diciano-4-(1h-indazol-5-il)-2,6-dimetil-1,4-dihidropiridina flúor substituídos e seus métodos de uso

Country Status (27)

Country Link
US (1) US9422263B2 (pt)
EP (1) EP2485726B1 (pt)
JP (1) JP5753175B2 (pt)
KR (1) KR20120091005A (pt)
CN (1) CN102573838B (pt)
AR (1) AR078486A1 (pt)
AU (1) AU2010305550A1 (pt)
BR (1) BR112012006842A2 (pt)
CA (1) CA2773676C (pt)
CL (1) CL2012000753A1 (pt)
CR (1) CR20120150A (pt)
CU (1) CU20120051A7 (pt)
DO (1) DOP2012000085A (pt)
EC (1) ECSP12011748A (pt)
ES (1) ES2458117T3 (pt)
HK (1) HK1172835A1 (pt)
IL (1) IL218415A0 (pt)
IN (1) IN2012DN02675A (pt)
MX (1) MX2012003603A (pt)
NZ (1) NZ599006A (pt)
PE (1) PE20121392A1 (pt)
RU (1) RU2012111695A (pt)
SG (1) SG178990A1 (pt)
TW (1) TW201124396A (pt)
UY (1) UY32922A (pt)
WO (1) WO2011042368A1 (pt)
ZA (1) ZA201201524B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009056886A1 (de) * 2009-12-03 2011-06-09 Bayer Schering Pharma Aktiengesellschaft cMet-Inhibitoren zur Behandlung der Endometriose

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3635977A (en) 1969-11-03 1972-01-18 American Cyanamid Co Certain 6-trifluoromethylcytosines and thiocytosines their synthesis and their use in the synthesis of uracisls and thiouracil
DK0379917T3 (da) 1989-01-26 1995-12-11 Bayer Ag Optisk aktive (meth)acrylsyre-drivater, deres fremstilling, deres polymerisation til optisk aktive polymere og disses anvendelse
DE19546136A1 (de) 1995-12-11 1997-06-12 Bayer Ag Chirale stationäre Phasen für die chromatographische Trennung von optischen Isomeren
TW200406385A (en) 2002-05-31 2004-05-01 Eisai Co Ltd Pyrazole compound and pharmaceutical composition containing the same
EP1720855A4 (en) 2004-03-02 2008-12-17 Smithkline Beecham Corp HEMMER OF ACT ACTIVITY
WO2005084672A1 (de) 2004-03-03 2005-09-15 Boehringer Ingelheim International Gmbh Ausgewählte cgrp-antagonisten, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
CA2589777A1 (en) 2004-12-13 2006-06-22 Irm Llc Compounds and compositions as modulators of steroidal receptors and calcium channel activities
CA2603676A1 (en) 2005-01-07 2006-07-13 Roskamp Research Llc Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
US7632839B2 (en) * 2005-01-19 2009-12-15 Merck & Co. Inc. Mitotic kinesin inhibitors
CL2007003609A1 (es) * 2006-12-14 2008-07-25 Bayer Schering Pharma Ag Compuestos derivados de dihidropiridinas sustituidas; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; proceso para producir la composicion farmaceutica; y uso en el tratamiento de una enfermedad mejorada con la inhibicion

Also Published As

Publication number Publication date
CA2773676A1 (en) 2011-04-14
US9422263B2 (en) 2016-08-23
DOP2012000085A (es) 2012-07-15
ZA201201524B (en) 2013-05-29
RU2012111695A (ru) 2013-10-10
EP2485726A1 (en) 2012-08-15
CN102573838A (zh) 2012-07-11
UY32922A (es) 2011-04-29
CN102573838B (zh) 2014-09-24
MX2012003603A (es) 2012-04-20
HK1172835A1 (en) 2013-05-03
CR20120150A (es) 2012-08-03
CU20120051A7 (es) 2012-06-29
WO2011042368A1 (en) 2011-04-14
ECSP12011748A (es) 2012-05-30
JP5753175B2 (ja) 2015-07-22
IN2012DN02675A (pt) 2015-09-04
CA2773676C (en) 2017-07-04
PE20121392A1 (es) 2012-10-14
ES2458117T3 (es) 2014-04-30
EP2485726B1 (en) 2014-03-12
CL2012000753A1 (es) 2012-09-14
AR078486A1 (es) 2011-11-09
IL218415A0 (en) 2012-04-30
US20120264785A1 (en) 2012-10-18
KR20120091005A (ko) 2012-08-17
NZ599006A (en) 2013-11-29
JP2013506699A (ja) 2013-02-28
SG178990A1 (en) 2012-04-27
TW201124396A (en) 2011-07-16
AU2010305550A1 (en) 2012-03-29

Similar Documents

Publication Publication Date Title
UY30779A1 (es) Derivados de dihidropiridina de utilidad como inhibidores de la proteina quinasa
ES2338590T3 (es) Procedimiento regioselectivo de preparacion de benzoimidazoltiofenos.
ECSP077985A (es) Inhibidores de proteina cinasa derivados de pirrol (2,3-b) piridina
CO6331304A2 (es) Derivados de tienopiridonas como activadores de proteina quinasa activados por amp (ampk)
TW200630356A (en) Polymorphic forms of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-E-[2-(pyridin-2-yl)ethenyl]indazole
EA200970402A1 (ru) Триазолопиридазиновые модуляторы протеинкиназ
EA200971077A1 (ru) Гетероциклические модуляторы киназы
CL2008001897A1 (es) Proceso para la preparacion de 3-halometil-1-metil-1h-pirazol, utiles como intermediario en la produccion de fungicidas; compuestos derivados de 3-halometil-1-metil-1h-pirazol.
ECSP10010599A (es) Derivados de tienopiridonas como activadores de proteina quinasa activados por amp (ampk)
UY30057A1 (es) Pirimidinas sustituidas con sulfoximinas, procesos para su producción y uso de las mismas como fármacos
EA201071045A1 (ru) Соединения оксадиазоантрацена для лечения диабета
CY1112495T1 (el) Κυτταροτοξικοι παραγοντες που περιλαμβανουν νεα παραγωγα τομαϋμυκινης
EA201171220A1 (ru) Мутанты fgf21 и их применение
EA201270758A1 (ru) Мутанты fgf21 и их применение
NO20091599L (no) Kjemiske forbindelser
EA200701930A1 (ru) Производные пиримидина для лечения гиперпролиферативных нарушений
UY29648A1 (es) Derivados de piridopirimidina, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones
BRPI0908406B8 (pt) Derivados de quinoxalinona, processo para a preparação dos mesmos, seu uso e composição farmacêutica
EA200970583A1 (ru) Способ получения пиперазиниловых и диазепаниловых производных бензамида
BR112016030730A8 (pt) composto
NO20083751L (no) Metoder for behandling av kognitive og andre sykdommer
UY29821A1 (es) Derivados de 5,6-dihidropirazolo(3,4)(1,4)diazepin-4(1h)-ona, procesos de preparación de dichos derivados, composiciones farmacéuticas conteniéndolos y aplicaciones.
BRPI0908569B8 (pt) estimuladores de secreção de insulina derivados de piridopirazinonas, seu uso, e composição farmacêutica
ATE407126T1 (de) Herstellung von (s)-4-fluormethyl-dihydro-furan-2-on
UY29631A1 (es) Derivados del 4,5-diarilpirrol, su preparación y su aplicación en terapéutica

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]